New Enterprise Associates

News, insights, analysis and data

← Back to New Enterprise Associates profile

New Enterprise Associates related stories

All articles and analysis

  • WaterBit grabs $11.4 mln Series A
    Iris Dorbian- 26 June 2018

    San Jose, California-based WaterBit, a precision irrigation company, has raised $11.4 million in Series A financing. New Enterprise Associates led the round with participation from TJ Rodgers, former CEO of Cypress Semiconductor and Heuristic Capital. In conjunction with the funding, NEA Managing General Partner Scott Sandell will join WaterBit's board of directors.

  • NEA leads funding in Catalog
    Alastair Goldfisher- 26 June 2018

    Boston-based Catalog, which develops DNA data storage technology, announced it has raised $9 million in funding led by New Enterprise Associates. Also participating in the round are OS Fund, Day One Ventures, messaging app Line, Data Collective, Green Bay Ventures, AME Cloud Ventures, Industry Ventures and others. The company was founded by MIT scientists Hyunjun Park and Nathaniel Roquet.

  • Long Hill Capital targets $200 mln for second venture fund
    Kaitlyn Landgraf Bartley- 20 June 2018

    Long Hill Capital is raising a second venture fund targeted at $200 million, according to a regulatory filing https://www.sec.gov/Archives/edgar/data/1743998/000174399818000001/xslFormDX01/primary_doc.xml

  • Top 10s: Software eats the venture world in May 2018
    Kaitlyn Landgraf Bartley- 13 June 2018
  • Online real estate marketplace Opendoor rakes in $325 mln
    Iris Dorbian- 13 June 2018

    San Francisco-based Opendoor, an online real estate marketplace, has secured $325 million in Series E funding. General Atlantic, Access Technology Ventures and Lennar Corporation led the round with participation from Andreessen Horowitz, Coatue Management, 10100 Fund, Invitation Homes, Norwest Venture Partners, Lakestar, GGV Capital, New Enterprise Associates and Khosla Ventures.

  • VC-backed Imara appoints new CEO
    Iris Dorbian- 13 June 2018

    Cambridge, Massachusetts-based Imara Inc, a clinical-stage biopharmaceutical company, has named Dr. Rahul D. Ballal as CEO. Previously, Ballal was at Northern Biologics and Versant Ventures where he was chief business officer and an entrepreneur-in-residence, respectively. Imara is backed by New Enterprise Associates, Pfizer Venture Investments, Lundbeckfond Ventures, Bay City Capital and Alexandria Venture Investments.